| VEGF-D promotes the metastatic spread of tumor cells via the lymphatics SA Stacker, C Caesar, ME Baldwin, GE Thornton, RA Williams, R Prevo, ... Nature medicine 7 (2), 186-191, 2001 | 1805 | 2001 |
| Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4) MG Achen, M Jeltsch, E Kukk, T Mäkinen, A Vitali, AF Wilks, K Alitalo, ... Proceedings of the National Academy of Sciences 95 (2), 548-553, 1998 | 1666 | 1998 |
| ICAM-1 (CD54): a counter-receptor for Mac-1 (CD11b/CD18). MS Diamond, DE Staunton, AR de Fougerolles, SA Stacker, ... The Journal of cell biology 111 (6), 3129-3139, 1990 | 1157 | 1990 |
| Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3 T Mäkinen, T Veikkola, S Mustjoki, T Karpanen, B Catimel, EC Nice, ... The EMBO journal 20 (17), 4762-4773, 2001 | 1101 | 2001 |
| Lymphangiogenesis and cancer metastasis SA Stacker, MG Achen, L Jussila, ME Baldwin, K Alitalo Nature Reviews Cancer 2 (8), 573-583, 2002 | 1027 | 2002 |
| Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice T Veikkola, L Jussila, T Makinen, T Karpanen, M Jeltsch, TV Petrova, ... The EMBO journal 20 (6), 1223-1231, 2001 | 911 | 2001 |
| Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease ML Hibbs, DM Tarlinton, J Armes, D Grail, G Hodgson, R Maglitto, ... Cell 83 (2), 301-311, 1995 | 861 | 1995 |
| Lymphangiogenesis and lymphatic vessel remodelling in cancer SA Stacker, SP Williams, T Karnezis, R Shayan, SB Fox, MG Achen Nature Reviews Cancer 14 (3), 159-172, 2014 | 754 | 2014 |
| Characterization of ICAM-2 and evidence for a third counter-receptor for LFA-1. AR de Fougerolles, SA Stacker, R Schwarting, TA Springer The Journal of experimental medicine 174 (1), 253-267, 1991 | 703 | 1991 |
| Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation P Baluk, T Tammela, E Ator, N Lyubynska, MG Achen, DJ Hicklin, ... The Journal of clinical investigation 115 (2), 247-257, 2005 | 687 | 2005 |
| Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes. ME Cooper, D Vranes, S Youssef, SA Stacker, AJ Cox, B Rizkalla, ... Diabetes 48 (11), 2229-2239, 1999 | 656 | 1999 |
| Sox18 induces development of the lymphatic vasculature in mice M Francois, A Caprini, B Hosking, F Orsenigo, D Wilhelm, C Browne, ... Nature 456 (7222), 643-647, 2008 | 569 | 2008 |
| Inhibition of Growth of C6 Glioma Cells in Vivo by Expression of Antisense Vascular Endothelial Growth Factor Sequence M Saleh, SA Stacker, AF Wilks Cancer research 56 (2), 393-401, 1996 | 567 | 1996 |
| VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses TT Rissanen, JE Markkanen, M Gruchala, T Heikura, A Puranen, ... Circulation research 92 (10), 1098-1106, 2003 | 525 | 2003 |
| Consensus guidelines for the use and interpretation of angiogenesis assays P Nowak-Sliwinska, K Alitalo, E Allen, A Anisimov, AC Aplin, R Auerbach, ... Angiogenesis 21, 425-532, 2018 | 502 | 2018 |
| VEGF‐C and VEGF‐D expression in neuroendocrine cells and their receptor, VEGFR‐3, in fenestrated blood vessels in human tissues TA Partanen, J Arola, A Saaristo, L Jussila, A Ora, M Miettinen, SA Stacker, ... The FASEB Journal 14 (13), 2087-2096, 2000 | 491 | 2000 |
| Biosynthesis of vascular endothelial growth factor-D involves proteolytic processing which generates non-covalent homodimers SA Stacker, K Stenvers, C Caesar, A Vitali, T Domagala, E Nice, S Roufail, ... Journal of Biological Chemistry 274 (45), 32127-32136, 1999 | 446 | 1999 |
| Focus on lymphangiogenesis in tumor metastasis MG Achen, BK McColl, SA Stacker Cancer cell 7 (2), 121-127, 2005 | 431 | 2005 |
| The role of tumor lymphangiogenesis in metastatic spread SA Stacker, ME Baldwin, MG Achen The FASEB Journal 16 (9), 922-934, 2002 | 420 | 2002 |
| Vascular endothelial growth factor D is dispensable for development of the lymphatic system ME Baldwin, MM Halford, S Roufail, RA Williams, ML Hibbs, D Grail, ... Molecular and cellular biology 25 (6), 2441-2449, 2005 | 404 | 2005 |
Marc G AchenPeter MacCallum Cancer Centre, Melbourne, Australia在 petermac.org 的电子邮件经过验证
